Concepedia

Ke Li

KL

Statistics

Publications

16

Citations

984

H-Index

14

Active since

2007

Affiliations

Yale University(Current)

WuXi AppTec (China)

Whitney Museum of American Art

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Ke Li is an author at Yale University specializing in molecular biology, oncology, and pharmacy.

ORCID

Publications per year

2007–2024

16

Publications

16

Targeted Degradation of Oncogenic KRAS <sup>G12C</sup> by VHL-Recruiting PROTACs

Michael J. Bond, Ling Chu, Dhanusha A. Nalawansha et al. · ACS Central Science · 2020 · 414 citations · Full text

, , +14

Azobenzene-Linked Porphyrin−Fullerene Dyads

David I. Schuster, Ke Li, Dirk M. Guldi et al. · Journal of the American Chemical Society · 2007 · 123 citations

, , +14

Total Synthesis of Camptothecin and Related Natural Products by a Flexible Strategy

Ke Li, Jinjie Ou, Shuanhu Gao · Angewandte Chemie International Edition · 2016 · 113 citations

, , +16

TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation

Ke Li, Feng Wang, Zhao-na Yang et al. · Nature Communications · 2020 · 60 citations · Full text

, , +17

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode

Jun Fujimoto, Osamu Kurasawa, Terufumi Takagi et al. · ACS Medicinal Chemistry Letters · 2019 · 41 citations · Full text

, , +13

1–5 of 16